Validation and verification of predictive salivary biomarkers for oral health.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 03 2021
Historique:
received: 12 08 2020
accepted: 24 02 2021
entrez: 20 3 2021
pubmed: 21 3 2021
medline: 27 10 2021
Statut: epublish

Résumé

Oral health is important not only due to the diseases emerging in the oral cavity but also due to the direct relation to systemic health. Thus, early and accurate characterization of the oral health status is of utmost importance. There are several salivary biomarkers as candidates for gingivitis and periodontitis, which are major oral health threats, affecting the gums. These need to be verified and validated for their potential use as differentiators of health, gingivitis and periodontitis status, before they are translated to chair-side for diagnostics and personalized monitoring. We aimed to measure 10 candidates using high sensitivity ELISAs in a well-controlled cohort of 127 individuals from three groups: periodontitis (60), gingivitis (31) and healthy (36). The statistical approaches included univariate statistical tests, receiver operating characteristic curves (ROC) with the corresponding Area Under the Curve (AUC) and Classification and Regression Tree (CART) analysis. The main outcomes were that the combination of multiple biomarker assays, rather than the use of single ones, can offer a predictive accuracy of > 90% for gingivitis versus health groups; and 100% for periodontitis versus health and periodontitis versus gingivitis groups. Furthermore, ratios of biomarkers MMP-8, MMP-9 and TIMP-1 were also proven to be powerful differentiating values compared to the single biomarkers.

Identifiants

pubmed: 33742017
doi: 10.1038/s41598-021-85120-w
pii: 10.1038/s41598-021-85120-w
pmc: PMC7979790
doi:

Substances chimiques

Biomarkers 0
TIMP1 protein, human 0
Tissue Inhibitor of Metalloproteinase-1 0
MMP8 protein, human EC 3.4.24.34
Matrix Metalloproteinase 8 EC 3.4.24.34
MMP9 protein, human EC 3.4.24.35
Matrix Metalloproteinase 9 EC 3.4.24.35

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6406

Références

J Periodontol. 2020 Jan;91(1):102-109
pubmed: 31343739
J Periodontol. 2014 Jan;85(1):113-22
pubmed: 23594192
Expert Opin Med Diagn. 2013 Jan;7(1):37-51
pubmed: 23335946
J Periodontol. 2017 Nov;88(11):1145-1152
pubmed: 28598286
Eur J Clin Invest. 2012 Feb;42(2):216-28
pubmed: 21726217
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Periodontol. 2012 Jan;83(1):79-89
pubmed: 21563952
J Clin Periodontol. 2017 Mar;44(3):238-246
pubmed: 27925695
Cytokine. 2019 Mar;115:135-141
pubmed: 30626536
Peptides. 2017 May;91:58-64
pubmed: 28363793
Hum Genomics. 2016 Aug 17;10(1):28
pubmed: 27531006
J Periodontol. 2010 Mar;81(3):384-91
pubmed: 20192865
Periodontol 2000. 2009;50:52-64
pubmed: 19388953
J Clin Immunol. 2013 Jan;33(1):271-9
pubmed: 22926406
J Clin Bioinforma. 2014 Oct 23;4:13
pubmed: 25379168
J Periodontol. 2016 Dec;87(12):1484-1491
pubmed: 27541079
Mol Oral Microbiol. 2012 Dec;27(6):409-19
pubmed: 23134607
Dis Markers. 2015;2015:341259
pubmed: 25814780
Adv Clin Chem. 2019;93:263-290
pubmed: 31655732
J Clin Periodontol. 2020 Nov;47(11):1304-1316
pubmed: 32777086
J Clin Periodontol. 2011 May;38(5):434-41
pubmed: 21480939
Periodontol 2000. 2016 Feb;70(1):142-63
pubmed: 26662488
Crit Rev Oral Biol Med. 1994;5(3-4):203-48
pubmed: 7703323
Med Decis Making. 1991 Apr-Jun;11(2):95-101
pubmed: 1865785
J Periodontol. 2014 Aug;85(8):e295-303
pubmed: 24502627
Proteomics Clin Appl. 2020 May;14(3):e1900050
pubmed: 31840410
Mol Cell Proteomics. 2018 Jul;17(7):1392-1409
pubmed: 29610270
Mol Diagn Ther. 2019 Oct;23(5):667-676
pubmed: 31372941
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):2036-2042
pubmed: 28502592
PLoS One. 2013 Dec 10;8(12):e81581
pubmed: 24339946
Oral Microbiol Immunol. 2007 Feb;22(1):52-60
pubmed: 17241171
J Immunol Methods. 2012 Mar 30;377(1-2):62-5
pubmed: 22306358
Front Cell Infect Microbiol. 2015 Aug 19;5:62
pubmed: 26347856
J Periodontol. 2014 Dec;85(12):1770-8
pubmed: 25079398
J Periodontal Res. 2007 Aug;42(4):287-93
pubmed: 17559623
J Dent Res. 1994 Aug;73(8):1397-406
pubmed: 8083435
Innate Immun. 2015 Aug;21(6):619-25
pubmed: 25712810
Sci Rep. 2019 Jul 30;9(1):11034
pubmed: 31363141
J Clin Periodontol. 2009 Aug;36(8):619-26
pubmed: 19558463
Clin Chim Acta. 2008 Aug;394(1-2):1-6
pubmed: 18455512
Proteomics. 2017 Feb;17(3-4):
pubmed: 27995754
JDR Clin Trans Res. 2019 Oct;4(4):352-359
pubmed: 31013451
J Dent Res. 2011 Jun;90(6):752-8
pubmed: 21406610
Periodontol 2000. 2018 Feb;76(1):68-84
pubmed: 29193353
Stud Health Technol Inform. 2016;224:61-6
pubmed: 27225554
Nat Biotechnol. 2006 Aug;24(8):971-83
pubmed: 16900146
Arch Oral Biol. 2007 Dec;52(12):1114-35
pubmed: 17692813
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
J Periodontol. 2013 Apr;84(4 Suppl):S85-S105
pubmed: 23631587
J Periodontol. 2018 Jan;89(1):117-129
pubmed: 28846062
Ann Periodontol. 1999 Dec;4(1):1-6
pubmed: 10863370
J Clin Periodontol. 1995 Oct;22(10):794-803
pubmed: 8682927
Mol Oral Microbiol. 2015 Aug;30(4):323-35
pubmed: 25787257
J Periodontol. 2018 Jan;89(1):58-66
pubmed: 28777039
J Periodontol. 2018 Jul;89(7):875-882
pubmed: 29608211
J Proteomics. 2014 Jul 31;107:24-30
pubmed: 24642211
J Periodontal Res. 2014 Feb;49(1):1-9
pubmed: 23601005
J Oral Sci. 2002 Mar;44(1):35-9
pubmed: 12058868
J Dent Res. 2013 Feb;92(2):161-5
pubmed: 23242230
Cent Eur J Immunol. 2019;44(4):440-446
pubmed: 32140057
J Clin Periodontol. 1997 Feb;24(2):110-4
pubmed: 9062857
Genome Med. 2016 Apr 21;8(1):44
pubmed: 27102203
Ann Med. 2006;38(5):306-21
pubmed: 16938801
Proteomics Clin Appl. 2008 Oct 1;2(10-11):1386-1402
pubmed: 20976028
J Clin Periodontol. 2011 May;38(5):428-33
pubmed: 21261673
Int J Mol Sci. 2020 Apr 11;21(8):
pubmed: 32290474

Auteurs

Nagihan Bostanci (N)

Section of Periodontology and Dental Prevention, Division of Oral Diseases, Department of Dental Medicine, Karolinska Institutet, Alfred Nobels Allé 8, 14104, Huddinge, Stockholm, Sweden. nagihan.bostanci@ki.se.

Konstantinos Mitsakakis (K)

Hahn-Schickard, Georges-Koehler-Allee 103, 79110, Freiburg, Germany.
Laboratory for MEMS Applications, IMTEK - Department of Microsystems Engineering, University of Freiburg, Georges-Koehler-Allee 103, 79110, Freiburg, Germany.

Beral Afacan (B)

Department of Periodontology, School of Dentistry, Aydin University, Hasan Efendi mah. Hastane cad. No:1 Efeler/Aydın, 09100, Istanbul, Turkey.

Kai Bao (K)

Section of Periodontology and Dental Prevention, Division of Oral Diseases, Department of Dental Medicine, Karolinska Institutet, Alfred Nobels Allé 8, 14104, Huddinge, Stockholm, Sweden.

Benita Johannsen (B)

Hahn-Schickard, Georges-Koehler-Allee 103, 79110, Freiburg, Germany.

Desirée Baumgartner (D)

Hahn-Schickard, Georges-Koehler-Allee 103, 79110, Freiburg, Germany.
Laboratory for MEMS Applications, IMTEK - Department of Microsystems Engineering, University of Freiburg, Georges-Koehler-Allee 103, 79110, Freiburg, Germany.

Lara Müller (L)

Hahn-Schickard, Georges-Koehler-Allee 103, 79110, Freiburg, Germany.

Hana Kotolová (H)

Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, 61242, Brno, Czech Republic.

Gülnur Emingil (G)

Department of Periodontology, School of Dentistry, Ege University, 35100, Bornova, İzmir, Turkey.

Michal Karpíšek (M)

Faculty of Pharmacy, Masaryk University, Palackeho trida 1946/1, 61242, Brno, Czech Republic. karpisek@biovendor.com.
BioVendor-Laboratorní Medicína a.s., Research and Diagnostic Products Division, Karasek 1767/1, Reckovice, 62100, Brno, Czech Republic. karpisek@biovendor.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH